←
Seth Cheetham798 posts
Seth Cheetham avatar

Seth Cheetham

@SethCheetham

Cheetham Lab @AIBNatUQ |Director @NationalBiolog2 | ARC Future Fellow | #mRNA drug discovery | nationalbiologicsfacility.co…

◷ Joined July 2017▧ 52 Photos and videos
Seth Cheetham avatar
Seth Cheetham@SethCheetham·10 Jun 2025

To accelerate #mRNA vaccine and therapy research, I'm excited to share our end-to-end protocol for #mRNA design, synthesis and encapsulation in @NatureProtocols. Protocol development by @LauraJLeighton, Natasha Chaudhary and Tim Mercer. @BASEmRNA nature.com/articles/s41596-0…

Seth Cheetham avatar
Seth Cheetham@SethCheetham·2 Apr 2025

Crucially, this approach doesn't require a new LNP, it works with FDA-approved formulations. We hope that this approach will enable targeted mRNA therapeutics for diverse diseases. Work led by Bettina Dietmair, James Humphries and Chirs Howard. @BASEmRNA @AIBNatUQ @TRI_info

Seth Cheetham avatar
Seth Cheetham@SethCheetham·2 Apr 2025

The technology is programmable and works with other targeting arms including anti-PSMA (highly expressed on prostate cancer cells) bispecifics.

Post attachment
Seth Cheetham avatar
Seth Cheetham@SethCheetham·2 Apr 2025

Bispecifics can be used by combining with the mRNA-LNP (pre-mixing) or the bispecific can be administered first (pre-targeting). 5/

Post attachment
Seth Cheetham avatar
Seth Cheetham@SethCheetham·2 Apr 2025

As proof of concept we used anti-EGFR bispecifics to deliver mRNA to mouse breast cancer xenografts. The mRNA-payload (luciferase) is very efficiently delivered in vivo. 4/

Post attachment
Seth Cheetham avatar
Seth Cheetham@SethCheetham·2 Apr 2025

To overcome this obstacle we developed bispecific antibodies that bind to PEG on the surface of LNPs and to cell-surface markers. 3/

Post attachment
Seth Cheetham avatar
Seth Cheetham@SethCheetham·2 Apr 2025

Getting a high dose of mRNA to target tissues is one of the toughest problems for broad use of mRNA-LNP therapies. When adminstered systemically mRNA-LNPs go the liver with little delivery to other tissues. 2/

Post attachment
Seth Cheetham avatar
Seth Cheetham@SethCheetham·2 Apr 2025

Systemic mRNA-LNP delivery beyond the liver? Check out our recent paper demonstrating cell-specific mRNA-LNP delivery using PEG- and target cell-specific antibodies. This approach can customised to any target cell-type with off-the-shelf mRNA-LNPs. 1/ sciencedirect.com/science/ar…

Seth Cheetham avatar
Seth Cheetham@SethCheetham·20 Mar 2025

Exited to share our latest preprint! mRNA-LNPs are efficiently delivered to healthy livers, but what about liver tumours? Our postdoc Laura Leighton found liver tumours efficiently take up mRNA, enabling next generation mRNA-LNP cancer therapeutics. biorxiv.org/content/10.1101/…

Post attachment
Prof Paul Beavis avatar
⟳ Seth Cheetham retweeted
Prof Paul Beavis@paulbeavis4·21 Jan 2025

Opportunity for a bioinformatician to join the lab @PeterMacRes to help us identify new Immunotherapies. Please reach out for further details. Ad is for a post doc but research assistants considered. 💻 🧬. See link below.

Seth Cheetham avatar
Seth Cheetham@SethCheetham·7 Jan 2025

It was fantastic collaborate with @Fer_NK_nando on this programme to develop CAR-NK therapies for sarcoma with #mRNA tech. These mRNA-enhanced NK cells can eliminate cancer cells in vitro and in vivo. Out now in Clinical and Translational Medicine. @TRI_info @AIBNatUQ @BASEmRNA

This tweet is unavailable